Troy A. Ignelzi
Troy A. Ignelzi has made 1 open-market purchase worth $144k since Oct 21, 2026, in 1 company. The latest: $144k of RAPP, filed Oct 21, 2026, scored 58 out of 100.
CFO, Rapport Therapeutics, Inc.
Follow Troy A. Ignelzi, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 21 Form 4 (opens sec.gov) |
RAPPRapport Therapeutics, Inc. · CFOCFO · Near 52-week low | +55% stake | 58 | $144k 5,500 at $26.10 |
−8.7% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −8.7% (0% up, 1 measured).
Questions
What stock has Troy A. Ignelzi bought?
RAPP (Rapport Therapeutics, Inc.), all on the open market and reported on SEC Form 4.
When did Troy A. Ignelzi last buy?
Oct 21, 2026: 5,500 shares of RAPP at $26.10, $144k in all (Form 4 (opens sec.gov)).
Has Troy A. Ignelzi filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Troy A. Ignelzi a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 21, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer